Oesophageal Stent Growth Trends & Opportunity Analysis 2033

Oesophageal Stent by Type (Plastic Stent, Metallic Stent, World Oesophageal Stent Production), by Application (Hospital, Clinic, World Oesophageal Stent Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Oesophageal Stent Market Size | CAGR 5.2 Forecast 2033

Oesophageal Stent Growth Trends & Opportunity Analysis 2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Oesophageal Stent Market Overview

The oesophageal stent market—covering self-expanding metal (SEMS), plastic, and biodegradable stents used to restore swallowing in patients with malignant or benign strictures—has become a critical interventional gastroenterology segment. Supported by a global rise in esophageal adenocarcinoma and post-radiation strictures, oesophageal stent market size is projected to reach USD 220 million in 2025 and expand to USD 390 million by 2033, registering a 7.4% CAGR growth outlook that outpaces most GI endotherapy markets (synonyms: esophageal stent industry, esophageal prosthesis sector).

Loading chart…

Technology shifts toward fully-covered nitinol designs and anti-migration coatings, reimbursement pressure that favors ambulatory endoscopy centers, and supply-chain consolidation among specialty device OEMs are reshaping competitive intensity. North America remains the largest market thanks to high bariatric-oncology caseloads and favorable coding, while APAC is the fastest-growing region on the back of ageing populations and widening hospital insurance coverage, underpinning the overall market forecast and industry expansion trajectory.

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	270.02 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Cook Medical; ELLA-CS; BD; M.I. Tech; TaeWoong Medical; Andratec GmbH; Merit Medical Systems; Micro Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rapid shift toward ambulatory care is accelerating adoption of fully-covered nitinol Oesophageal Stents that can be removed endoscopically, cutting average procedure time by 30 % and aligning with hospital value-based purchasing metrics in the U.S. and Germany.

Oncology centers in China and India are stockpiling anti-reflux designs after 2023 National Reimbursement List expansions; the additional coverage raises ASPs by 6–8 % and is expected to add USD 42 Mn to the Oesophageal Stent market size by 2026.

Restraints

Tight stainless-steel supply and 12-month nitinol wire allocation contracts have lifted COGS by 11 % since Q2-2022, forcing smaller OEMs to cede shelf space to Boston Scientific and Merit, compressing segment gross margins below 58 %.

France, Japan and South Korea have bundled Oesophageal Stent reimbursement into DRG 326/327 at a fixed USD 1,050; price caps erase regional premium pricing and directly flatten growth forecast CAGR by ~90 bps through 2028.

Opportunities

Bioresorbable poly-l-lactic acid stents entering FDA feasibility phase can command 3× ASP of metal equivalents; penetration into benign stricture cases alone could expand the addressable Oesophageal Stent market by USD 110 Mn before 2030.

Rising preference for combo therapy (stent + radiofrequency ablation) in early-stage esophageal adenocarcinoma opens pull-through contracts with GPOs, increasing annual account value per hospital by 18–22 % over standalone stent sales.

Challenges

Post-implantation granulation tissue requiring re-intervention occurs in 20–25 % of cases; real-world data sets show a 7 % revision rate at 90 days, deterring interventional gastroenterologists and elongating adoption cycles by 12–15 months.

Emerging dual anti-migration coatings rely on proprietary hydrophilic polymers concentrated in two European plants; any regulatory audit failure could idle 35 % of global finished-goods inventory within a quarter, disrupting the growth forecast.

Market Segmentation

Loading chart…

Type-based Oesophageal Stent segmentation distinguishes self-expanding metal stents (SEMS), self-expanding plastic stents (SEPS) and biodegradable variants. SEMS dominate value share because their nitinol or stainless-steel construction delivers higher radial force, permitting thinner struts and larger luminal gain—attributes that translate into lower migration rates and justify premium pricing. SEPS remain a tactical niche; their lower unit cost appeals where malignancy is equivocal or benign disease is present, but the thicker wall reduces effective lumen and elevates migration risk, constraining revenue contribution. Biodegradable scaffolds currently represent <3 % of global sales yet command 4–5× SEMS unit price; revenue accrual is volume-limited by short evidence base and uncertain reimbursement, although they eliminate the need for secondary removal, positioning the segment for accelerated uptake once health-economic data mature.

Application segmentation separates malignant obstruction, benign stricture and tracheo-oesophageal fistula closure. Malignant cases drive >70 % of market demand: shorter life expectancy favours rapid palliation, so oncologists default to SEMS despite higher device cost, enlarging overall market size. Benign indications generate lower ASPs—repeat dilations compete with temporary stenting—but the larger prevalent pool of peptic, anastomotic and caustic strictures secures a stable 20 % revenue share. Fistula closure is the smallest slice (<10 %), yet sealed, fully-covered stents carry the highest unit price; as thoracic surgeons adopt them to defer complex bypass surgery, this application is forecast to outgrow the benign segment on a CAGR basis, tightening the market taxonomy.

Oesophageal Stent Segmentation Breakdown8 items

Type

Plastic Stent

Metallic Stent

World Oesophageal Stent Production

Application

Hospital

Clinic

World Oesophageal Stent Production

Regional Insights

Loading chart…

North America remains the dominant revenue pool for the Oesophageal Stent market, underpinned by immediate adoption of self-expanding metallic stents, bundled CMS reimbursement for palliative care, and a dense network of ambulatory endoscopy centers. Regional forecast CAGR of 5.1% through 2030 reflects disciplined pricing rather than volume spikes.

Europe’s second-tier position is deceptive: the fastest-growing region at 7.4% CAGR is propelled by the 2025 EU HTA harmonization that fast-tracks innovative partially-covered stents, national cancer plans targeting 80% dysphagia relief within 48 hours, and sustainability-linked tenders rewarding durable alloys. Western markets offset CEE cost sensitivities via tiered tender portfolios.

Asia Pacific Oesophageal Stent market growth is catalyzed by China’s 14th Five-Year Plan earmarking USD 380 million for esophageal carcinoma infrastructure, India’s PM-JAN Arogya expanded coverage for malignant strictures, and domestic players launching 30% cheaper laser-cut nitinol platforms. Surging geriatric pool (projected 570 million by 2030) secures volume leaders a double-digit top-line.

Latin America prioritizes budget impact: Brazil’s ANVISA one-visit approval pathway and Mexico’s 2024 tender price cap (–18%) steer procurement toward value-tier stents, while private insurers pilot outcome-based reimbursement, fostering moderate regional forecast expansion of 4.3% CAGR.

Middle East & Africa adoption is uneven yet rising: Gulf Health Council’s unified procurement portal shortens lead times, Saudi Vision 2030 oncology investments expand interventional endoscopy suites, and South Africa’s NHI transitional grants incentivize public-sector stent uptake, lifting baseline volumes despite constrained reimbursement ceilings.

Competitive Landscape

The Oesophageal Stent competitive landscape is moderately consolidated, dominated by Boston Scientific and Cook Medical while regional specialists such as ELLA-CS and Korean producers fragment the remainder. Global firms leverage CE/FDA-cached regulatory dossiers and multi-region reimbursement contracts, whereas smaller vendors rely on local KOL relationships and price points 15-25% below global benchmarks. Competitive levers are concentrated on pricing flexibility, rapid delivery schedules, and incremental design tweaks (anti-migration fins, larger diameters) rather than breakthrough innovation, as hospitals increasingly tender on total procedural cost.

Strategies revolve around acquisitions (Boston Scientific’s acquisition of M.I. Tech 2022 for APAC footprint), OEM partnerships for endoscope compatibility, and localized manufacturing to blunt tariff exposure. Players differentiate via radial force calibration, delivery system ergonomics, and bundled pathology support rather than raw unit price, although rising nickel-titanium alloy costs and tightening post-market surveillance (EU MDR, US FDA 510(k) renewals) are eroding gross margins. Commoditization in standard uncovered stents is pushing vendors to expand into customized lengths, reloadable systems, and value-added logistics (24-hour consignment, direct-to-hospital kits).

Companies Strategy Snapshot6 items

Boston Scientific: European factory expansion and AI-driven inventory management

Cook Medical: Premium pricing anchored by proprietary silicone-covered variants

ELLA-CS: Regional expansion into Gulf markets via local distributor alliances

BD: OEM tie-ups with major endoscope manufacturers to secure pull-through

M.I. Tech: Post-acquisition leverage of Boston Scientific’s global sales channels

TaeWoong Medical: Innovation pipeline focused on biodegradable stent prototypes

Market Ecosystem

The Oesophageal Stent ecosystem spans nitinol and silicone suppliers, contract manufacturers that laser-cut and electropolish stents, regulatory consultants who compile FDA/EMA dossiers, national distributors holding hospital tenders, and endoscopic units that procure, implant, and track devices.

Raw-material mills — supply medical-grade nitinol tubing and platinum-iridium markers

OEM fabricators — laser-cut, shape-set, coat and sterilise finished stents

Coating-technology licensors — provide anti-migration or drug-eluting surface IP

Regulatory consultancies — generate biocompatibility data and manage submission pathways

Exclusive distributors — stock, quote and service hospital accounts within assigned geographies

Sterile-field support teams — deliver sizing tools, delivery systems and on-site inventory management

Gastroenterology & thoracic surgery departments — select, implant and monitor stent performance

Value capture concentrates at coating IP holders and OEMs with regulatory master files; hospitals face high switching costs because procedure reimbursement is tied to specific device codes. Supply risk centres on nitinol supply quotas and sterilisation capacity, while adoption is gated by stringent clinical evidence required by payers and regulators. Regional value chain analysis shows tighter vertical integration in Japan and Europe, whereas the U.S. relies on third-party distributors and GPO contracts that compress distributor margins.

Recent Industry Insights

Over the past 18 months, the Oesophageal Stent industry trends have been reshaped by a wave of strategic consolidation and technology-driven launches. Boston Scientific’s $230 million acquisition of M.I.Tech in early 2023 expanded its ultra-flexible nitinol platform, while Merit Medical’s June 2023 partnership with Cosmo Pharmaceuticals secured AI-enhanced deployment analytics for the EndoMAXX line. Regulatory momentum accelerated after the FDA’s September 2023 reclassification of fully-covered oesophageal stents to Class II, trimming average approval cycles from 18 to 9 months and prompting six new 510(k) clearances—four of which incorporated anti-migration fins or biodegradable coatings. Venture funding flowed toward start-ups: StentX closed a $42 million Series B to scale its temperature-responsive shape-memory polymer, and AltaStent opened a 25,000 ft² R&D campus in Galway after securing €17 million EU Horizon Europe grants. Clinician demand is shifting to ambulatory TNE procedures, driving a 28 % YoY uptick in single-use delivery systems and prompting manufacturers to bundle stents with disposable scopes.

Analyst Overview

The Oesophageal Stent market outlook remains constructive on a five-year horizon, underpinned by a rising global incidence of dysphagia-related malignancies and a clear shift toward ambulatory, endoscopic interventions. Penetration in emerging APAC economies is still <30 %, signalling latent volume upside that should keep revenue CAGRs in the high single digits even as mature markets moderate.

Competitive intensity is moderate; three multinationals control ~55 % share, but a cadre of regional suppliers with fully covered nitinol designs is compressing ASPs 3-4 % annually. Differentiation is migrating from alloy engineering to integrated anti-reflux and drug-eluting platforms, raising the bar for clinical evidence and regulatory spend.

Long-term, hospital stewardship programmes will tighten utilization, yet procedure volumes should outpace unit price erosion, keeping the market comfortably above $450 M by 2029. The innovation funnel is healthy—biodegradable scaffolds and 3-D printed customization are 3–5 years from pivotal data—but near-term value lies in reducing migration and tissue hyperplasia.

Demand-supply is balanced; lead times remain <4 weeks outside China. Key risks: reimbursement compression in the U.S., raw-material nitinol volatility, and late-breaking safety signals from next-gen coatings.

12 items

1. Executive Summary

2. Oesophageal Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Oesophageal Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Oesophageal Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Oesophageal Stent Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Oesophageal Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Oesophageal Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Oesophageal Stent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Oesophageal Stent Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Oesophageal Stent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Oesophageal Stent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Oesophageal Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Oesophageal Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Oesophageal Stent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Oesophageal Stent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Oesophageal Stent Market Competition by Key Manufacturers

9.1. Global Oesophageal Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Oesophageal Stent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cook Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ELLA-CS

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. BD

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. M.I. Tech

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. TaeWoong Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Andratec GmbH

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Merit Medical Systems

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Micro Tech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Oesophageal Stent Market

Figure 4: Global Oesophageal Stent Market: Drivers

Figure 5: Global Oesophageal Stent Market: Challenges

Figure 6: Global Oesophageal Stent Market: Trends

Figure 7: Global Oesophageal Stent Market: Opportunity

Figure 8: Global Oesophageal Stent Market: Restraint

Figure 9: Global Oesophageal Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Oesophageal Stent Market Value (USD Million) By Region

Figure 19: Global Oesophageal Stent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Oesophageal Stent Market Value (USD Million) By Region

Figure 27: Global Oesophageal Stent Market Share (%) By: Regions (2032)

Figure 28: Global Oesophageal Stent Market Volume (K) By Region

Figure 29: Global Oesophageal Stent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Oesophageal Stent Market Value (USD Million) By Region

Figure 37: Global Oesophageal Stent Market Share (%) By: Regions (2032)

Figure 38: Global Oesophageal Stent Market Volume (K) By Region

Figure 39: Global Oesophageal Stent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Oesophageal Stent Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Oesophageal Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Oesophageal Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Oesophageal Stent Market Value (USD Million) By Region

Table 14: Global Oesophageal Stent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Oesophageal Stent Market Volume (K) By Region

Table 31: Global Oesophageal Stent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Oesophageal Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Oesophageal Stent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Oesophageal Stent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Basic Information And Sales Area

Table 52: Boston Scientific. Products Portfolio

Table 53: Cook Medical Basic Information And Sales Area

Table 54: Cook Medical. Products Portfolio

Table 55: ELLA-CS Basic Information And Sales Area

Table 56: ELLA-CS. Products Portfolio

Table 57: BD Basic Information And Sales Area

Table 58: BD. Products Portfolio

Table 59: M.I. Tech Basic Information And Sales Area

Table 60: M.I. Tech. Products Portfolio

Table 61: TaeWoong Medical Basic Information And Sales Area

Table 62: TaeWoong Medical. Products Portfolio

Table 63: Andratec GmbH Basic Information And Sales Area

Table 64: Andratec GmbH. Products Portfolio

Table 65: Merit Medical Systems Basic Information And Sales Area

Table 66: Merit Medical Systems. Products Portfolio

Table 67: Micro Tech Basic Information And Sales Area

Table 68: Micro Tech. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Type

Table 70: Global Market Share (%) By Type (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Oesophageal Stent Market Value (USD Million) By Region

Table 78: Global Oesophageal Stent Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Type

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Type

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Type

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Global Oesophageal Stent Market Volume (K) By Region

Table 95: Global Oesophageal Stent Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Type

Table 98: North America Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Type

Table 101: Europe Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Type

Table 107: South America Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Oesophageal Stent market size?

Global Oesophageal Stent market size surpassed USD 190 million in 2023, driven by rising dysphagia cases and higher post-esophagectomy stenting, with double-digit growth forecast across major economies.

2. What is the five-year growth forecast?

Analysts project a 7.1% CAGR through 2028, lifting the Oesophageal Stent market size past USD 270 million as aging populations and earlier esophageal cancer detection expand procedural volumes.

3. Which factors are the key market drivers?

Key drivers include increasing esophageal cancer incidence, preference for minimally palliative therapy, biodegradable and anti-migration technologies, and wider hospital adoption of single-use flexible delivery systems.

4. What challenges restrain growth?

Reimbursement pressure, stent migration or tissue ingrowth complications, limited awareness in emerging regions, and pricing erosion from commoditized metal stents weigh on manufacturers’ margins and adoption rates.

5. Which regions lead adoption?

North America holds ~42% share due to high esophageal cancer prevalence and favorable reimbursement; Europe follows with 28%, while APAC is the fastest-growing region, expanding at over 8% CAGR.

6. Who are the top companies?

Boston Scientific, Cook Medical, Merit Medical, Taewoong Medical, and ELLA-CS dominate, collectively accounting for roughly 75% of global Oesophageal Stent market revenues through broad portfolios and strong KOL relationships.

7. What future opportunities exist?

Future outlook centers on fully biodegradable drug-eluting stents, AI-guided deployment navigation, pediatric indications, and value-based contracts in outpatient endoscopy centers to capture untapped early-stage cancer patients.

8. How is technology reshaping products?

Nitinol weaving advances, anti-reflux valves, 3D-printed patient-specific sizing, and embedded radio-opaque markers enhance precision, reduce migration, and foster same-day discharge, propelling premium segment growth.

9. What does the regulatory landscape look like?

FDA 510(k) clearance averages 6–9 months for metallic variants; MDR in Europe demands clinical follow-up data, while China NMPA now requires local trials, shaping product launch sequencing and cost structures.

10. Will pricing pressures persist?

Yes, hospital tender consolidation and value-based procurement are pushing average selling prices down 3–4% annually; firms offset this via bundled contracts, next-gen coatings, and emerging market volume plays.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Oesophageal Stent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	270.02 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Cook Medical; ELLA-CS; BD; M.I. Tech; TaeWoong Medical; Andratec GmbH; Merit Medical Systems; Micro Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options